Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Enlyte’s Q2 Medical Price Index Shows Increases In Comp and Auto Injury Services
New report reveals current trends for P&C industry SAN DIEGO, Calif.—Medical costs nationally have risen 11% in workers
Workers' Comp
Podcast
Return-to-work strategies for LGBTQ+ Injured Employees
Workers' Comp
Article
Looking Beyond the Numbers of Enlyte’s Medical Price Index
Each quarter, Enlyte publishes its medical price index (MPI), which analyzes Enlyte’s medical bill review professional services charge data for tre
Workers' Comp
Article
Enlyte Quarterly Medical Price Index - Q2
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the
Workers' Comp
Article
Enlyte Pharmacists Discuss a Changing Workers’ Comp Pharmacy Landscape
Workers' compensation pharmacy is constantly evolving, from tackling the opioid crisis, to the rise of compounding pharmacies, to the pandemic.
Workers' Comp
Article
Enlyte Pharmacy Experts Speak on Turning Challenges Into Opportunities
Clients face numerous challenges in managing their workers' compensation pharmacy programs including capturing all pharmacy utilization and costs a